1 |
Gabay C, Kushner I (1999). Acute-phase proteins and other systemic responses to inflammation. New Engl J Med, 340, 448-54.
DOI
ScienceOn
|
2 |
Chaturvedi AK, Caporaso NE, Katki HA, et al (2010). C-reactive protein and risk of lung cancer. J Clin Oncol, 28, 2719-26.
DOI
ScienceOn
|
3 |
Degenhardt K, Mathew R, Beaudoin B, et al (2006). Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell, 10, 51-64.
DOI
ScienceOn
|
4 |
Disis ML. (2010). Immune regulation of cancer. J Clin Oncol, 28, 4531-8.
DOI
ScienceOn
|
5 |
Hedges LV, Vevea JL. (1998). Fixed-and random-effects models in meta-analysis. Psychological methods, 3, 486.
DOI
ScienceOn
|
6 |
Huang C J, Teng HW, Chien CC, Lin JK, Yang SH (2013). Prognostic significance of C-reactive protein polymorphism and KRAS/BRAF in synchronous liver metastasis from colorectal cancer. PloS one, 8, 65117.
DOI
ScienceOn
|
7 |
Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, Botella J (2006). Assessing heterogeneity in meta-analysis: Q statistic or index? Psychological methods, 11, 193.
DOI
ScienceOn
|
8 |
Kivimaki M, Lawlor DA, Smith GD, et al (2007). Variants in the CRP gene as a measure of lifelong differences in average c-reactive protein levels the cardiovascular risk in young Finns Study, 1980-2001. Am J Epidemiol, 166, 760-4.
DOI
ScienceOn
|
9 |
ABunt SK., Yang L, Sinha P, et al (2007). Reduced inflammation in the tumor microenvironment delays the accumulation of myeloid-derived suppressor cells and limits tumor progression. Cancer Res, 67, 10019-26.
DOI
ScienceOn
|
10 |
Canna K, McArdle PA, McMillan DC, et al (2005). The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer, 92, 651-4.
DOI
ScienceOn
|
11 |
Wen W., Cai Q, Xiang YB, et al (2008). The modifying effect of C-reactive protein gene polymorphisms on the association between central obesity and endometrial cancer risk. Cancer, 112, 2409-16.
DOI
ScienceOn
|
12 |
Tsilidis KK, Helzlsouer KJ, Smith MW, et al (2009). Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Cause Control, 20, 1739-51.
DOI
|
13 |
Xu M, Zhu M, Du Y, et al (2013). Serum C-reactive protein and risk of lung cancer: a case-control study. Med Oncol, 30, 1-6.
|
14 |
Yang SH, Huang CJ, Chang SC, Lin JK (2011). Association of C-reactive protein gene polymorphisms and colorectal cancer. Ann Surg Oncol, 18, 1907-15.
DOI
|
15 |
Shimada H, Nabeya Y, Okazumi SI, et al (2003). Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol, 83, 248-52.
DOI
ScienceOn
|
16 |
Ognjanovic S, Yamamoto J, Saltzman B, et al (2010). Serum CRP and IL-6, genetic variants and risk of colorectal adenoma in a multiethnic population. Cancer Causes Control, 21, 1131-8.
DOI
ScienceOn
|
17 |
Siemes C, Visser LE, Coebergh JW, et al (2006). C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clini Oncol, 24, 5216-22.
DOI
ScienceOn
|
18 |
Pierce BL, Biggs ML, DeCambre M, et al (2009). C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older. Cancer Causes Control, 20, 1193-03.
DOI
ScienceOn
|
19 |
Poole EM., Bigler J, Whitton J, et al (2009). C-reactive protein genotypes and haplotypes, polymorphisms in NSAIDmetabolizing enzymes, and risk of colorectal polyps. Pharmacogenet Genom, 19, 113-20.
DOI
|
20 |
Siegel R, Naishadham D, Jemal A (2013). Cancer statistics, 2013. CA: Cancer J Clini, 63, 11-30.
DOI
ScienceOn
|
21 |
Slattery ML, Curtin K, Poole E, et al (2011). Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival. Int J Cancer, 128, 2726-34.
DOI
ScienceOn
|
22 |
Song CQ,Zhang JH,Shi JC, et al (2014). Bioinformatic prediction of SNPs within miRNA binding sites of inflammatory genes associated with gastric cancer. Asian Pac J Cancer Prev, 15, 937-42
DOI
ScienceOn
|
23 |
Suk HJ, Ridker PM, Cook NR, Zee RY (2005). Relation of polymorphism within the C-reactive protein gene and plasma CRP levels. Atherosclerosis, 178, 139-45.
DOI
ScienceOn
|
24 |
Lange LA, Carlson CS, Hindorff LA, et al (2006). Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA: J Am Med Assoc, 296, 2703-11.
DOI
ScienceOn
|
25 |
Kohler A, Eggers H, Kuczyk MA, Schrader AJ, Steffens S (2013). Utility of the serum CRP value for assessing the prognosis and therapeutic response of urological malignancies. Aktuel Urol, 44, 452-5.
DOI
ScienceOn
|
26 |
Lin M, Huang J, Zhu J, Shen H (2013). Elevated pre-treatment levels of high sensitivity C-reactive protein as a potential prognosticator in patients with colorectal cancer. Exp Ther Med, 6, 1369.
|
27 |
Koma Y, Onishi A, Matsuoka H, et al (2013). Increased red blood cell distribution width associates with cancer stage and prognosis in patients with lung cancer. PloS one, 8, 80240.
DOI
|
28 |
Kong M, Lee C (2012). Genetic associations with C-reactive protein level and white blood cell count in the KARE study. Int J Immunogenet, 40, 120-5
|
29 |
Li QQ, Lu ZH,Yang L, et al (2014). Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy. Asian Pac J Cancer Prev, 15, 945-50
DOI
ScienceOn
|
30 |
Maccio A, Lai P, Santona MC, et al (1998). High serum levels of soluble IL-2 receptor, cytokines, and C reactive protein correlate with impairment of T cell response in patients with advanced epithelial ovarian cancer. Gynecol Oncol, 69, 248-52.
DOI
ScienceOn
|
31 |
Motoyama S, Miura M, Hinai Y, et al (2009). C-reactive protein 1059G>C genetic polymorphism influences serum C-reactive protein levels after esophagectomy in patients with thoracic esophageal cancer. J Am Coll Surgeons, 209, 477-83.
DOI
ScienceOn
|
32 |
Motoyama S, Nakatsu T, Miura M, et al (2013). A CRP genetic polymorphism associated with the tumoral expression of CRP in esophageal cancer. Surg Today, 43, 339-40.
DOI
ScienceOn
|
33 |
Guo YZ, Pan L, Du CJ (2013). Association between C-reactive protein and risk of cancer:a meta-analysis of prospective cohort studies. Asian Pac J Cancer Prev, 14, 243-8
DOI
ScienceOn
|
34 |
Ueno H, Okada S, Okusaka T, Ikeda M (2000). Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapy. Oncology, 59, 296-301.
DOI
ScienceOn
|
35 |
Khreiss T, Jozsef L, Hossain S, et al (2002). Loss of pentameric symmetry of C-reactive protein is associated with delayed apoptosis of human neutrophils. J Biol Chem, 277, 40775-81.
DOI
ScienceOn
|